Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Thumbnail

Imaging considerations included in tattoo guidelines for at-risk cancer population

Cases of mistaken malignancy have become more common as the popularity of tattoos has grown in recent years.

nuc med treatment for non-hodgkin lymphoma

New nuclear medicine treatment could potentially cure non-Hodgkin lymphoma

“If testing is successful in humans, this would represent an excellent new treatment option for patients with this disease.” 

Thumbnail

Radiologists outperform commercially available AI in PI-RADS scoring

The findings contradict prior research that utilized the same software, experts involved in the research noted. This could be due to out-of-distribution data for the DL software, which could impair its performance. 

Thumbnail

Projected supply and demand of radiation oncology: Can the workforce keep up?

In years past, concerns have been raised over whether a growing radiation oncology workforce would eventually outpace patient demands, but a new report brings positive news.

Chemical imaging method could improve radiotherapy planning

A team of experts has been researching a method known as photo acoustic chemical imaging, or PACI, to understand how it can offer added insight into the chemical makeup of a tumor.  

womanconsultation.jpg

Older women with breast cancer can safely forego radiation therapy

New data suggest that it may not be necessary for women older than 65 with hormone receptor-positive breast cancer to undergo radiotherapy after breast-conserving surgery and hormone therapy, as it does not impact death rates or metastasis risk.

#DCIS #invasivebreastcancer #cancerupgrade #breastMRI

Ultrafast MRI predicts breast cancer upgrade

Preoperative ultrafast MRI could help guide biopsy and surgical management decision in patients with ductal carcinoma in situ. 

FDA grants passage to autonomous, biology-guided radiotherapy

A therapeutic oncology company has been cleared to market a cancer treatment that that turns a tumor’s own biology into a self-signaling target for radiation therapy.